NEOGEN Neogen Chemicals Q3 FY25 results (Oct–Dec 2024) and concall
Neogen Chemicals reported a robust Q3 FY25, with strong revenue and EBITDA growth driven by BuLi Chem ramp-up and base business volume gains. The company is actively progressing its battery materials projects, with significant CAPEX deployed and commercial production for the Greenfield facility on track for FY26. While short-term battery chemical revenue targets for FY25 and FY26 were revised downwards due to demand delays, the long-term outlook remains positive with strategic customer engagements and capacity expansions.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 |
|---|---|
| Revenue | 22 |
| EBITDA | 38 |
| Net profit | 14 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
